EUVIMEDEUVIMED entdecken
Metaanalyse

Effectiveness of calcimimetics on fractures in dialysis patients with secondary hyperparathyroidism: meta-analysis of randomized trials

Takuya Wakamatsu, Suguru Yamamoto, Koji Matsuo, Masatomo Taniguchi, Takayuki Hamano, Masafumi Fukagawa, Junichiro James Kazama

Journal of Bone and Mineral Metabolism · 2024-05 · 42 (3) · 316-325

DOI: 10.1007/s00774-024-01500-y ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Journal of Bone and Mineral Metabolism, online erschienen am 27.03.2024. Verfasst von Takuya Wakamatsu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Rheumatology, Niigata City General Hospital, Niigata, Japan. Hauptthemen laut MEDLINE: Hyperparathyroidism, Secondary, Calcimimetic Agents, Renal Dialysis, Randomized Controlled Trials as Topic. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: This study aimed to assess the effectiveness of calcimimetics in reducing the risk of fractures in dialysis patients with secondary hyperparathyroidism (SHPT). MATERIAL AND METHODS: A comprehensive literature search was conducted using PubMed, Embase, and Cochrane Library for articles published through December 9, 2023. The quality of each trial was evaluated using the Cochrane Collaboration tool. Meta-analysis was performed using a random-effects model, and effect measures across studies were synthesized. The risk ratio (RR) and 95% confidence interval (CI) were used to quantify the risk of fracture. RESULTS: We identified seven studies involving 6481 dialysis patients with SHPT. The administration of calcimimetics reduced fracture incidence compared to placebo or conventional treatment (RR: 0.50, 95% CI 0.29-0.88, p = 0.02). Calcimimetics demonstrated a low number needed to treat (NNT) to prevent an incident fracture (NNT: 47). CONCLUSION: The use of calcimimetics offers a significant benefit in reducing the risk of fractures in patients undergoing dialysis with SHPT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperparathyroidism, SecondaryCalcimimetic AgentsRenal DialysisRandomized Controlled Trials as TopicFractures, BoneHumans

Stichwörter der Autor:innen

CalcimimeticsDialysisFractureMeta-analysisParathyroid hormone

Substanzen

Calcimimetic Agents

Autor:innen und Institutionen

  • Department of Nephrology and Rheumatology, Niigata City General Hospital, Niigata, Japan.
  • Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachi-dori, Niigata, 951-8510, Japan. yamamots@med.niigata-u.ac.jp.
  • Division of Nephrology, Niigata Shirone General Hospital, Niigata, Japan.
  • Fukuoka Renal Clinic, Fukuoka, Japan.
  • Department of Nephrology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
  • Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.

Zitieren

APA

Wakamatsu, T., Yamamoto, S., Matsuo, K., Taniguchi, M., Hamano, T., Fukagawa, M., & Kazama, J. J. (2024). Effectiveness of calcimimetics on fractures in dialysis patients with secondary hyperparathyroidism: meta-analysis of randomized trials. Journal of Bone and Mineral Metabolism, 42(3), 316-325. https://doi.org/10.1007/s00774-024-01500-y

Vancouver

Wakamatsu T, Yamamoto S, Matsuo K, Taniguchi M, Hamano T, Fukagawa M, et al. Effectiveness of calcimimetics on fractures in dialysis patients with secondary hyperparathyroidism: meta-analysis of randomized trials. Journal of Bone and Mineral Metabolism. 2024;42(3):316-325. doi:10.1007/s00774-024-01500-y

BibTeX
@article{Wakamatsu2024,
  author = {Wakamatsu, Takuya and Yamamoto, Suguru and Matsuo, Koji and Taniguchi, Masatomo and Hamano, Takayuki and Fukagawa, Masafumi and Kazama, Junichiro James},
  title = {Effectiveness of calcimimetics on fractures in dialysis patients with secondary hyperparathyroidism: meta-analysis of randomized trials},
  journal = {Journal of Bone and Mineral Metabolism},
  year = {2024},
  volume = {42},
  number = {3},
  pages = {316--325},
  doi = {10.1007/s00774-024-01500-y}
}
Kostenlos starten →